OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Cell International is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia	412
Amino acid-based risk stratification model improves prognostic precision in diffuse large B-cell lymphoma	277
PMA exerts anti-leukemia effect in Ph+ ALL through activating PKC δ and its down-stream molecules	241
miR-196a-5p promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting LIFR	223
Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma	176
MicroRNAome profiling of breast cancer unveils hsa-miR-5683 as a tumor suppressor microRNA predicting favorable clinical outcome	137
Shared molecular mechanisms of common differentially expressed genes (C-DEGs) linking gallbladder stones to carcinogenesis: integrated bioinformatics and experimental validation	125
CDK4 inhibition by luteolin enhances lenvatinib sensitivity in HCC via Wnt/β-catenin modulation	117
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics	106
SETDB1 promotes gastric cancer progression via UPR and mTOR pathway	106
Evaluation of functional magnetic resonance APT and DKI imaging for breast cancer	99
Unraveling the role of the solute carrier family in hepatocellular carcinoma: mechanisms and therapeutic prospects	97
A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma	91
OTUD3 inhibits breast cancer cell metastasis by regulating TGF-β pathway through deubiquitinating SMAD7	86
Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation	86
Human amniotic epithelial cells exert anti-cancer effects through secretion of immunomodulatory small extracellular vesicles (sEV)	83
Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75	81
Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies	81
Transcription factor MYB regulates glycolysis to promote the transfer and malignant progression of gastric cancer through the SSBP2/ISL1 axis	80
Low NDFIP1-driven metabolic alterations in CD8 + T cells: implications for immune evasion and therapy resistance in HNSC	79
Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma	78
Melanoma biology and treatment: a review of novel regulated cell death-based approaches	77
The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C	74
Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers	72
Cuproptosis: a promising new target for breast cancer therapy	72

New models for MPNST: establishment and comprehensive characterization of two tumor cell lines	70
Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer	68
Curcumin attenuates smoking and drinking activated NF-κB/IL-6 inflammatory signaling axis in cervical cancer	65
Assessment of the anticancer and antimetastatic effects of monocarbonyl analogs of curcumin, C66 and B2BrBC, in breast cancer cells	63
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives	62
Targeting the CCL5/CCR5-PI3K-AKT axis suppresses hepatic stellate cell-induced breast cancer metastasis	62
Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways	60
ASPM promotes the progression of esophageal squamous cell carcinoma by upregulating the expression of HMMR	59
Venetoclax synergizes with Wnt/β-catenin inhibitor C-82 in acute myeloid leukemia by increasing the degradation of Mcl-1 protein	58
Molecular and phenotypic characterization of 5-FU resistant colorectal cancer cells: toward enrichment of cancer stem cells	57
Deciphering 17-β-hydroxysteroid dehydrogenase 4: from molecular insights to cancer therapeutics	57
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities	56
Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT	56
Mortalin promotes the evolution of androgen-independent prostate cancer through Wnt/β-catenin signaling pathway	55
TAGLN: a stiffness-driven prognostic biomarker for metastatic colorectal cancer	54
KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma	53
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression	53
Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis	53
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer	53
Revealing a novel Decorin-expressing tumor stromal subset in hepatocellular carcinoma via integrative analysis single-cell RNA sequencing	52
Etiology of polyploid giant cancer cells: a new frontier in cancer biology	52
Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cells	51
Molecular mechanisms of microRNA-216a during tumor progression	50
SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling	50
Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer	50